Bicarbonate

Bicarbonate

SCHEMBL27388751

O=C(O)O.O=S(=O)(O)c1cccc2ccccc12

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
TTR P02766 2/20 0.53
F2 P00734 2/20 0.51
PRSS1 P07477 2/20 0.51
PRSS2 P07478 2/20 0.51
PRSS3 P35030 2/20 0.51
TSHR P16473 1/20 0.51
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
SLC1A3 P43003 1/20 0.49
SLC1A2 P43004 1/20 0.49
SLC1A1 P43005 1/20 0.49
NR4A1 P22736 2/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
CTRB1 P17538 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL27645889 0.98 CA1 (0.55) CA1CA2CA9TTRF2
Benzene SCHEMBL8992706 0.96 CA1 (0.61) CA1CA2CA9TTRF2
SCHEMBL27719293 0.94 CA1 (0.63) CA1CA2CA9TTRF2
SCHEMBL29358913 0.94 CA1 (0.63) CA1CA2CA9TTRF2
SCHEMBL4323 0.94 CA1 (0.63) CA1CA2CA9TTRF2
SCHEMBL30304762 0.94 CA1 (0.63) CA1CA2CA9TTRF2
Phosphine SCHEMBL25249741 0.92 CA1 (0.61) CA1CA2CA9TTRF2
SCHEMBL5684936 0.92 CA1 (0.61) CA1CA2CA9TTRF2
Water SCHEMBL8193333 0.92 CA1 (0.61) CA1CA2CA9TTRF2
SCHEMBL22735026 0.92 CA1 (0.61) CA1CA2CA9TTRF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1070399-A The amide derivatives oxytocin antagonist that piperizinylcamphorsuoxytocin replaces MERCK & CO INC (US) 1993-03-31 CN disclosed